These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37872649)

  • 1. Using (1,3)-β-D-glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis.
    Nyuykonge B; Siddig EE; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet SM; Fahal AH; van de Sande WWJ
    Mycoses; 2024 Jan; 67(1):e13664. PubMed ID: 37872649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wako β-D-glucan assay can be used to measure serum β-D-glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis.
    Nyuykonge B; Siddig E; Mhmoud NA; Bakhiet S; Zijlstra E; Verbon A; Fahal AH; van de Sande WWJ
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):783-786. PubMed ID: 36201367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
    Nyuykonge B; Siddig EE; Mhmoud NA; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
    Mycoses; 2022 Dec; 65(12):1170-1178. PubMed ID: 36005544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
    Nyuykonge B; Lim W; van Amelsvoort L; Bonifaz A; Fahal A; Badali H; Abastabar M; Verbon A; van de Sande W
    Mycoses; 2022 Jun; 65(6):650-655. PubMed ID: 35398930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
    Lim W; Konings M; Parel F; Eadie K; Strepis N; Fahal A; Verbon A; van de Sande WWJ
    Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35064672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim.
    Lim W; Eadie K; Konings M; Rijnders B; Fahal AH; Oliver JD; Birch M; Verbon A; van de Sande W
    J Antimicrob Chemother; 2020 Apr; 75(4):936-941. PubMed ID: 31904836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive, aggressive mastoid bone eumycetoma: a treatment challenge.
    Yosif AA; Bakhiet SM; Abdalla TH; Mhmoud NA; Siddig EE; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):431-435. PubMed ID: 33682008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.
    Eadie K; Parel F; Helvert-van Poppel M; Fahal A; van de Sande W
    Trop Med Int Health; 2017 Jun; 22(6):696-702. PubMed ID: 28342219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report.
    Mekoguem C; Triboulet C; Gouveia A
    J Med Case Rep; 2019 Feb; 13(1):32. PubMed ID: 30755254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple extensive Madurella mycetomatis eumycetoma lesions: a case report and review of the literature.
    Zaid DM; Bakheet OE; Ahmed ES; Abdalati F; Mhmoud NA; Mohamed ESW; Bakhiet SM; Siddig EE; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):411-414. PubMed ID: 33406268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Last generation triazoles for imported eumycetoma in eleven consecutive adults.
    Crabol Y; Poiree S; Bougnoux ME; Maunoury C; Barete S; Zeller V; Arvieux C; Pineau S; Amazzough K; Lecuit M; Lanternier F; Lortholary O;
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3232. PubMed ID: 25299610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metagenomic detection of eumycetoma causative agents   from households of patients residing in two Sudanese endemic villages in White Nile State.
    Santona A; Mhmoud NA; Siddig EE; Deligios M; Fiamma M; Paglietti B; Bakhiet SM; Rubino S; Fahal AH
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010385. PubMed ID: 36040926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach.
    Lim W; Siddig E; Eadie K; Nyuykonge B; Ahmed S; Fahal A; Verbon A; Smit S; van de Sande WW
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008897. PubMed ID: 33326425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study.
    Khatri ML; Al Kubati SAS; Gaffer IA; Majeed SMA
    Indian J Dermatol Venereol Leprol; 2022; 88(5):615-622. PubMed ID: 35389029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Madurella mycetomatis grains within a eumycetoma lesion are clonal.
    Nyuykonge B; Siddig EE; Konings M; Bakhiet S; Verbon A; Klaassen CHW; Fahal AH; van de Sande WWJ
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35833294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico.
    Nyuykonge B; Klaassen CHW; Zandijk WHA; de Hoog GS; Ahmed SA; Desnos-Ollivier M; Verbon A; Bonifaz A; van de Sande WWJ
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1828-1834. PubMed ID: 32233084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal Activity of Natural Naphthoquinones and Anthraquinones against Madurella mycetomatis.
    Ma J; Todd M; van de Sande WWJ; Biersack B
    Chem Biodivers; 2023 May; 20(5):e202300151. PubMed ID: 37067830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eumycetoma due to Madurella mycetomatis acquired in Jamaica.
    Fletcher CL; Moore MK; Hay RJ
    Br J Dermatol; 2001 Dec; 145(6):1018-21. PubMed ID: 11899126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan.
    Ahmed A; Adelmann D; Fahal A; Verbrugh H; van Belkum A; de Hoog S
    J Clin Microbiol; 2002 Mar; 40(3):1031-6. PubMed ID: 11880433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis.
    Fahal AH; Rahman IA; El-Hassan AM; Rahman ME; Zijlstra EE
    Trans R Soc Trop Med Hyg; 2011 Mar; 105(3):127-32. PubMed ID: 21247608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.